National Beverage FIZZ 深 滬
等待開盤 09-24 09:30:00 美东时间
30.65
-0.470
-1.51%
華盛通- 最 高31.30
- 今 開31.14
- 成交量 28.67万股
- 最 低 30.3552
- 昨 收 31.12
- 總市值 28.69亿
- 52周最高 34.955
- 市盈率 靜 15.63
- 換手率 0.31%
- 52周最低 27.50
- 委 比 51.32%
- 總股本 9361.53万
- 歷史最高 88.715
- 量 比 0.62
- 振 幅 3.04%
- 歷史最低 -8.845
- 每 手 1
- 風險率 1.48%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 机构看淡消费股！麦当劳、耐克、卡夫亨氏齐遭降目标价；能源股获齐声唱多
今日重点评级关注：Ascendiant Capital：维持SurgePays"买入"评级，目标价从3.5美元升至3.75美元；HC Wainwright & Co.：维持Spero Therapeutics"买入"评级，目标价从5美元升至6美元
09-15 15:30
UBS Maintains Sell on National Beverage, Lowers Price Target to $31
UBS analyst Peter Grom maintains National Beverage (NASDAQ:FIZZ) with a Sell and lowers the price target from $32 to $31.
09-14 22:06
National Beverage shares are trading lower after the company reported worse-than-expected Q1 financial results.
National Beverage shares are trading lower after the company reported worse-than-expected Q1 financial results.
09-11 19:52
National Beverage Q1 EPS $0.50 Misses $0.59 Estimate, Sales $330.662M Miss $342.080M Estimate
National Beverage (NASDAQ:FIZZ) reported quarterly earnings of $0.50 per share which missed the analyst consensus estimate of $0.59 by 15.25 percent. This is a 16.67 percent decrease over earnings of $0.60 per share from the same period last year. The company reported quarterly sales of $330.662 mil...
09-11 05:01
UBS Maintains Sell on National Beverage, Lowers Price Target to $32
UBS analyst Peter Grom maintains National Beverage (NASDAQ:FIZZ) with a Sell and lowers the price target from $33 to $32.
09-04 21:56
These consumer staples stocks show weak RSI ahead of Q2 results
Consumer staples stocks are drawing investor attention as the second-quarter earnings season gathers momentum this week, with market participants assessing whether recent weakness has created potentia...
07-20 22:15
Why Q32 Bio Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Shares of Q32 Bio Inc (NASDAQ:QTTB) rose sharply in pre-market trading as the company said it will report 36-week topline results from Part B of the SIGNAL-AA Phase 2a clinical trial on Monday. Q32 Bio shares jumped 29.6% to $14.53 in pre-market trading. Here are some other stocks moving in pre-mark...
07-13 16:39
Rivian Automotive, Tenax Therapeutics, Robinhood And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Dow Jones index gaining around 450 points on Thursday. Shares of Rivian Automotive Inc (NASDAQ:RIVN) rose sharply on Thursday after the company released second-quarter production and delivery figures and raised full year delivery forecast. The company produced 12,61...
07-02 22:24
美股大行评级 | 潜在涨幅90.66%！Tango Therapeutics获杰富瑞升目标价至60美元，上调至"买入"评级
今日重点评级关注：杰富瑞：上调Tango Therapeutics评级至"买入"，目标价从27美元升至60美元；Susquehanna：维持安森美半导体"积极"评级，目标价从120美元升至140美元
06-29 15:49
UBS Maintains Sell on National Beverage, Lowers Price Target to $33
UBS analyst Peter Grom maintains National Beverage (NASDAQ:FIZZ) with a Sell and lowers the price target from $35 to $33.
06-27 02:34
